GK

Gaurav Khandelwal

Active Director Director DIN 02684163
DIN 02684163 First appointment Jul 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Jul 2009
Shareholding value •••• Premium profile

About Gaurav Khandelwal

Data last updated:

Gaurav Khandelwal is a Director at Rasik Remedies Private Limited (since 2009), Director at Safpure Lifesciences Private Limited (since 2013) and Director at Shri Shyam Prime Commodities Private Limited (since 2012). The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹106 Cr; the largest is Rasik Remedies Private Limited at ₹76.75 Cr (FY 2024).

DIN 02684163
Primary Designation Director
Industry Healthcare
First Appointment 07 Jul 2009
Oldest Company Age 17 yrs
Largest company Rasik Remedies Private Limited · ₹76.75 Cr (FY 2024)
Combined revenue ₹106 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rasik Remedies Private Limited U51397RJ2009PTC029310
Director07 Jul 20092009₹76.75 Cr (FY 2024)Active
Safpure Lifesciences Private Limited U24232RJ2013PTC042203
Director22 Apr 20132013₹29.57 Cr (FY 2025)Active
Director29 Mar 20122012₹11 Lakh (FY 2020)Active

Directorship timeline

Open interactive timeline →
Safpure Lifesciences Private Limited
Rasik Remedies Private Limited
Shri Shyam Prime Commodities Private Limited
Premium access

Shareholding and investment profile for Gaurav Khandelwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Khandelwal

Gaurav Khandelwal currently holds 3 directorships: Rasik Remedies Private Limited (Director, since 07 Jul 2009, revenue ₹76.75 Cr (FY 2024)); Safpure Lifesciences Private Limited (Director, since 22 Apr 2013, revenue ₹29.57 Cr (FY 2025)); Shri Shyam Prime Commodities Private Limited (Director, since 29 Mar 2012, revenue ₹11 Lakh (FY 2020)).

Gaurav Khandelwal was first appointed on 07 Jul 2009 as Director at Rasik Remedies Private Limited. The most recent appointment on record is 22 Apr 2013 at Safpure Lifesciences Private Limited.

The 3 current companies of Gaurav Khandelwal that report revenue have a combined latest revenue of ₹106 Cr: Rasik Remedies Private Limited ₹76.75 Cr (FY 2024); Safpure Lifesciences Private Limited ₹29.57 Cr (FY 2025); Shri Shyam Prime Commodities Private Limited ₹11 Lakh (FY 2020).

The current boards of Gaurav Khandelwal's companies include Kali Charan Das Khandelwal (Rasik Remedies Private Limited), Kishan Gopal Khandelwal (Rasik Remedies Private Limited), Narendra Kumar Khandelwal (Rasik Remedies Private Limited), Poonam Khandelwal (Rasik Remedies Private Limited), Saroj Khandelwal (Rasik Remedies Private Limited), Sourabh Khandelwal (Rasik Remedies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available